Glycomics-based serum markers as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection-Reference-Cited by-同舟云学术

Glycomics-based serum markers as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection

Published:2022-05-03 Issue:2 Volume:78 Page:96-102
ISSN:1784-3286
Container-title:Acta Clinica Belgica
language:en
Short-container-title:Acta Clinica Belgica

Author:

Somers Nicky¹²^ORCID,Vandekerckhove Elisabeth¹²,Geerts Anja¹²,Degroote Helena¹²,Lefere Sander²³,Devisscher Lindsey³,Meuris Leander⁴⁵,Callewaert Nico⁴⁵,Van Vlierberghe Hans¹²,Verhelst Xavier¹²^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology, Ghent University Hospital, Ghent, Belgium

2. Hepatology Research Unit, Liver Research Center Ghent, Ghent University, Ghent, Belgium

3. Immunopharmacology Unit, Department of Basic and Applied Medical Sciences; Liver Research Center Ghent, Ghent UniversityGut-Liver, Ghent, Belgium

4. Department of Biochemistry and Microbiology, VIB-UGent Center for Medical Biotechnology, Ghent, Belgium

5. Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17843286.2022.2072110

Reference25 articles.

1. Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection

2. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

3. Hepatic steatosis and fibrosis: Non-invasive assessment

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune hepatitis displays distinctively high multi-antennary sialylation on plasma N-glycans compared to other liver diseases;Journal of Translational Medicine;2024-05-14

2. Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma;Alimentary Pharmacology & Therapeutics;2023-10-25

3. Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach;Advances in Cancer Research;2023